We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Injectable, Grain-of-Rice-Sized Glucose Biosensor Continuously Measures Sugar Levels

By HospiMedica International staff writers
Posted on 27 Nov 2023

The first glucose self-monitoring system, developed in 1970, was a bulky device weighing three pounds and requiring a substantial blood sample, primarily intended for use in physicians' offices. More...

Since then, continuous glucose monitors (CGMs) have evolved significantly, but even modern versions can be cumbersome and their maintenance may discourage users. To overcome these limitations, researchers are now developing a fully injectable CGM, as small as a grain of rice, which can be paired with an external optical reader to measure sugar levels at any time.

A research team at Texas A&M Engineering (College Station, TX, USA) has secured a grant from the National Science Foundation (NSF) to work on this innovative project. The aim is to create a minimally invasive, injectable glucose biosensor and a corresponding wearable device. The sensor, once injected under the skin, is designed to work with a watch-like reader that uses light to determine glucose levels. This reader then transmits the data to a smartphone, allowing the user to easily share information with their healthcare provider.

In addition to the sensor’s unique size and injectability, the optical sensing technology used in the sensor and wearable reader is particularly suited for individuals with darker skin tones, a demographic that has faced challenges with biosensing technologies. The researchers are currently enhancing the sensor's biocompatibility by enclosing its sensing chemistry within a thermoresponsive membrane. This specialized membrane is designed to subtly adapt within the body, swelling and shrinking just enough to prevent cell and protein adhesion, thereby reducing the likelihood of scar tissue formation around the sensor. The team has already patented this membrane technology and is exploring its potential applications in various medical devices, aiming to extend their functional lifespan.

“The membrane could be applied to assorted devices that are prone to adhesion processes in the body,” said co-principal investigator Dr. Melissa Grunlan. “It could be used on maybe a catheter to prevent thrombosis and infection by preventing the accumulation of proteins, cells, and organisms.”

Related Links:
Texas A&M Engineering 


Gold Member
12-Channel ECG
CM1200B
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Mobile X-Ray Machine
MARS 15 / 30
New
Multifunctional Patient Floor Lift
Maxi Move 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.